PRODUCT DETAILS

About Irbecard-H 150mg/12.5mg Tablet

IRBESARTAN+HYDROCHLOROTHIAZIDE is an 'anti-hypertensives' medication primarily used for lowering high blood pressure (hypertension) by removing extra fluid (electrolytes) from the body. High blood pressure is a chronic condition in which the blood's force against the artery wall is high. As a result, it increases the risk of heart-related diseases like heart attack, heart failure, stroke, irregular heartbeat, and other complications.

Uses of Irbecard-H 150mg/12.5mg Tablet

Hypertension (high blood pressure)

Medicinal Benefits of Irbecard-H 150mg/12.5mg Tablet

IRBESARTAN+HYDROCHLOROTHIAZIDE is primarily used to reduce high blood pressure. It is a combination of two medicines, namely: Irbesartan and Hydrochlorothiazide. Irbesartan is an angiotensin receptor blocker (ARB) that blocks the hormone angiotensin, thereby relaxing and widening the narrowed blood vessels. This allows the blood to flow more smoothly in the blood vessels, and the heart can pump more efficiently. On the other hand, Hydrochlorothiazide is a diuretic or water pill that works by removing extra water/fluid and certain electrolytes overload from the body. Together, IRBESARTAN+HYDROCHLOROTHIAZIDE lowers the fluid overload, raised blood pressure, improves blood flow, and reduce the future risk of a heart attack and stroke.

Directions for Use

IRBESARTAN+HYDROCHLOROTHIAZIDE should not be used unless prescribed by a doctor. Always take IRBESARTAN+HYDROCHLOROTHIAZIDE exactly as your doctor told you. Your doctor will advise you how often you take your tablets based on your medical condition. Swallow IRBESARTAN+HYDROCHLOROTHIAZIDE with a full glass of water.

Side Effects of Irbecard-H 150mg/12.5mg Tablet

• Nausea
• Taste change
• Upset stomach
• Diarrhoea
• Dizziness
• Headache
• Electrolyte imbalance
  • Decreased blood pressure

Similar Drugs

For informational purposes only. Consult a doctor before taking any medicines.

In-Depth Precautions and Warning

Drug Warnings

Inform your doctor before taking IRBESARTAN+HYDROCHLOROTHIAZIDE, if you are already taking medicine that has aliskiren in it, if you have diabetes or kidney problems, if you have severe liver disease, if you suffer from gout, potassium deficiency (hypokalaemia)/sodium deficiency (hyponatraemia). Stop taking IRBESARTAN+HYDROCHLOROTHIAZIDE if you experience pronounced gastrointestinal troubles, blood count changes, disorders of the central nervous system, allergic reaction.  Inform your doctor before taking IRBESARTAN+HYDROCHLOROTHIAZIDE about all your ongoing medications. Your doctor may check your blood pressure, kidney function, and the number of electrolytes in the blood at regular intervals. IRBESARTAN+HYDROCHLOROTHIAZIDE should not be given to children and adolescents under 18 years of age. Drink sufficient quantities of liquid while on this medication. If you are pregnant or breastfeeding, do not take IRBESARTAN+HYDROCHLOROTHIAZIDE as it is a category D pregnancy drug and can harm the baby.

Drug Interactions

Drug-Drug Interaction:

Drug-drug interactions: This medicine may interact with aliskiren (medicine for high blood pressure), lithium (medicine for the major depressive disorder), painkillers, Metformin (diabetes medicine), Allopurinol (medicine for jaundice), Cholestyramine (medicine for diarrhoea), Vitamin D supplements, Carbamazepine (medicine for epilepsy), and Methyldopa (medicine for hypertension).

Drug-Disease Interaction:

 The efficacy of IRBESARTAN+HYDROCHLOROTHIAZIDE is affected, and the disease condition may even worsen if taken in patients with a recent or history of heart attack, low blood pressure, low potassium level, low electrolytes (sodium, potassium, calcium, etc.), severe liver disease, anuria (non-passage of urine), angioedema (an allergic condition with swelling under the skin), kidney disease, asthma, diabetes.

Safety Advice

ALCOHOL

You are recommended not to consume alcohol and IRBESARTAN+HYDROCHLOROTHIAZIDE to avoid unpleasant side effects like drowsiness, dizziness, and liver damage.

PREGNANCY

IRBESARTAN+HYDROCHLOROTHIAZIDE is not recommended during pregnancy as it is a category D pregnancy drug. This medicine may cause fetal damage and can affect the unborn baby (fetus).

BREAST FEEDING

IRBESARTAN+HYDROCHLOROTHIAZIDE is known to pass breast milk, but its effect on the baby is not known. So, before breastfeeding, let your doctor know about this.

DRIVING

Drive with caution, IRBESARTAN+HYDROCHLOROTHIAZIDE usually causes drowsiness and affects driving ability

LIVER

IRBESARTAN+HYDROCHLOROTHIAZIDE to be taken with caution, especially if you have had a history of liver disease. Your doctor will have to change the dosage depending on your medical condition and your reaction to treatment.

KIDNEY

IRBESARTAN+HYDROCHLOROTHIAZIDE to be taken with caution, especially if you have had a history of kidney disease. Your doctor will have to change the dosage depending on your medical condition and your reaction to treatment.